Uterine endometrium is one of the most important organs for species preservation. However, the physiology of human endometrium remains poorly understood, because the human endometrium undergoes rapid and large changes during each menstrual cycle and it is very difficult to investigate human endometrium as one organ. This remarkable regenerative capacity of human endometrium strongly suggests the existence of adult stem cells, and physiology of endometrium cannot be explained without adult stem cells. Therefore, investigating endometrial stem/progenitor cells should lead to a breakthrough in understanding the normal endometrial physiology and the pathophysiology of endometrial neoplastic disorders, such as endometriosis and endometrial cancer. Several cell populations have been discovered as putative endometrial stem/progenitor cells. Emerging evidence reveals that the endometrial side population (SP) is one of the potential endometrial stem/progenitor populations. Of all the endometrial stem/progenitor cell candidates, the endometrial SP (ESP) is best investigated in vitro and in vivo, and has the largest number of references. In this review, we provide an overview of the accumulating evidence for the ESP cells, both directly from human endometria and from cultured endometrial cells. Furthermore, SP cells are compared to other potential stem/progenitor cells, and we discuss their stem cell properties. We also discuss the difficulties and unsolved issues in endometrial stem cell biology.
INTRODUCTION: BACKGROUND ON SIDE POPULA-TION CELLS
Hematopoietic stem cells have attracted attention over the past decades, and knowledge of their features is the most advanced in the field of adult stem cell biology. These stem cells generate all hematopoietic lineages required to support life during the life span. Hematopoietic stem cells can be purified by differential staining based on the efflux of fluorescent vital dyes, such as rhodamine 123 and the DNAbindings dye, Hoechst 33342 [1, 2] . Dual-wavelength flow cytometric analysis of murine Hoechst 33342-stained bone marrow cells revealed a small fraction of cells (''side population'' [SP]) displaying low Hoechst fluorescence [3] . This SP fraction was found to be highly enriched for hematopoietic stem cells capable of long-term reconstitution in recipient mice that received a lethal dose of radiation [3, 4] . Human, rhesus, and miniature swine bone marrow cells also contain an SP [5] . The low fluorescence of this distinct population is mainly due to molecular pumping of Hoechst out of the cells via the ATP-binding cassette transporter G2 (ABCG2/Bcrp1), a plasma membrane transporter [6, 7] . However, while ABCG2 was proven not essential in conferring stemness [7] , the SP phenotype may be a universal marker of adult stem cell activity [8] . Indeed, SP cells have been investigated and studied as a stem cell population in a variety of adult tissues, such as bone marrow [3, [5] [6] [7] 9 ], brain [10] , cornea [11] , retina [12] , heart [13] , lung [14] , mammary gland [15] , liver [16] , kidney [17] , testis [18] , skin [19] , and skeletal muscle [20] . The SP phenotype is invaluable for the initial isolation of novel stem cell populations in the absence of defined cell-surface markers.
SP DERIVED FROM CULTURED ENDOMETRIAL CELLS
Endometrial SP (ESP) cells were first identified in shortterm cultures of endometrial cells [21] . Most SP cells were found in the CD9 (endometrial epithelial marker)-negative and CD13 (endometrial stromal marker)-negative fraction, expressing neither CD45 (leukocyte common antigen) nor CD34 [21] . SP cells sorted from short-term cultured endometrial cells (cESPs) were maintained in culture for 3 mo, while main population (MP; which includes the replicating population, together also known as non-SP) cells from short-term cultured endometrial cells (cEMPs) became senescent within 3 mo [21] . cESPs derived from the epithelial-enriched fraction culture formed aggregates and differentiated into gland-like structures expressing CD9 and E-cadherin, both epithelial markers, after a further 2-mo culture on collagen-coated dishes [21] . cESPs from the stromal-enriched fraction appeared to be fibroblastlike and expressed CD13 after 5-mo culture on collagen-coated dishes [21] . Differentiation of SP cells into these two mature endometrial cell types provides further evidence for both endometrial epithelial and stromal stem/progenitor cells. In addition, it has been reported that cESPs from unfractionated endometrial cell suspensions showed ''decidualization,'' morphologic and functional changes characteristic of secretory endometrial stromal cells when treated with estradiol and progesterone [22] , indicating the functional potential of cESPs.
THE PROPORTION OF ESP CELLS
The percentage of cESPs from 17 stromal-enriched fractions was significantly greater during menstruation than during the proliferative and secretory phases [21] , while the percentage of SP cells isolated freshly from 17 human endometria (fESPs) in the proliferative phase was significantly greater than in the secretory phase [22] . We categorized 48 endometrial samples into 4 stages: early proliferative (including menstruation), late proliferation, early secretory and late secretory phases. In our study, the proportion of fESPs (Fig. 1A) was the highest at the early proliferative phase and decreased gradually until its nadir in the late secretory phase (Fig. 1C) [23] . This decline of fESPs may result from dilution with increasing numbers of freshly isolated EMP (fEMP) cells as the functionalis grows and increases in thickness. We speculate that the absolute number of fESPs is stable throughout menstrual cycle, which is in agreement with the concept of adult stem cells being a small resident population, and that fEMPs are generated from fESPs, mainly in the functionalis, until just before menstruation. Furthermore, there is no significant difference throughout reproductive life in the percentage of SP cells isolated freshly from either the stromal-or epithelial-enriched fractions [24] .
Using a BALB/c mouse model of endometrial injury, an increase in the proportion of SP cells was demonstrated several hours after a peritoneal injection of lipopolysaccharide as an injury inducer [25] . Moreover, the increase was only observed in the presence of estrogen, but not with progesterone or a combination of estrogen and progesterone [25] . The rapid response of ESPs to injury or hormonal influences cannot be examined in humans, but are interesting findings. On the other hand, in Institute of Cancer Research mice, SP cells were isolated only from postpartum endometrium, not from endometrium with normal estrus cycles [26] . It was also demonstrated that serum estradiol levels changed in the same manner as the proportion of ESP cells in postpartum mice [27] , which may indicate that estrogen is prerequisite for increasing the proportion of SP cells in murine endometria.
THE CLONOGENIC CAPACITY OF ESP CELLS
cESPs showed a greater clonal colony-forming efficiency (clonogenic capacity) than cEMPs, while fESPs did not proliferate efficiently in conventional media [22, 23] . Although we cultured fESPs efficiently in vitro, the clonogenic capacity of fESPs in our optimized medium was significantly lower than that of fEMPs [23] . This suggests a possible difference in the cell cycle progression between cESPs and fESPs. Indeed, it has been reported that fESPs were largely in the G0 phase (85%), whereas cESPs had been recruited into G1 and progressed to G2/M/S stages, probably by culturing with cEMPs before flow cytometry sorting [22] . Therefore, even if cESPs are derived from fESPs, it should be recognized that cESPs have different characteristics compared with fESPs. In fact, the cESP's Hoechst pattern appears different from that of fESPs, even in the same sample (Fig. 1, A and B) . SP cells sorted directly from other tissues were also quiescent and predominantly in the G0 phase of the cell cycle [28] [29] [30] . Evidence suggests that adult stem cells are quiescent in vivo and, for this reason, BrdU label-retaining cell (LRC) methods have been widely used to identify stem/ progenitor cells [31] [32] [33] [34] .
The varied clonogenic capacity observed between endometrial stem/progenitor candidates may be explained by knowledge generated from the numerous studies on hematopoietic stem cells. The hierarchy of hematopoietic cells is based on the length of time the clonogenic colony-forming assay is conducted. Detection of the most primitive hematopoietic cell types is based on long-term bone marrow clonal culture. In the case of human bone marrow, a 5-to 8-wk time period between initiating cultures and assessing clonogenic progenitor numbers allows quantification of a very primitive cell in the starting population, the so-called long-term culture-initiating cell [35] . In contrast, more mature, committed progenitors of the various hematopoietic cell classes can be quantitated by a number of short-term in vitro clonogenic assays [36] . Furthermore, it has been suggested that most cells capable of long-term repopulation in vivo may not be detected as clonogenic colonyforming cells in standard culture systems [37, 38] . We tested the clonal efficiency (clonogenic capacity) of fESPs and fEMPs after 14-day culture [23] . A small number of committed progenitors observed in the fEMPs may be transit-amplifying cells, whereas quiescent endometrial stem cells highly enriched in fESPs may require more time to be recruited from G0 before differentiating into transit-amplifying cells. The initial slow growth rate of large colony (.4000 cells) -forming units [39] may also be explained by the quiescence of freshly isolated stem cells. Large colony-forming unit cells finally produce around one billion cells [39] [40] [41] , which concurs with the high telomerase activity (high proliferation potential) of fESPs [24] . Freshly isolated ESPs may be the same as large colony-forming unit cells.
Recently, we demonstrated that magnetic bead-selected W5C5-positive endometrial stromal cells had significantly higher clonal capacity compared to flow cytometry-sorted W5C5-positive cells, although the purity of W5C5 cells separated by flow cytometry sorting is greater than by magnetic beads [42] . This may suggest that flow cytometry sorting has detrimental effects on the viability of fESPs, and may explain their low clonogenic capacity [23] .
It has been demonstrated that uterine myometrial SP cells exhibited a higher proliferative capacity when cultured under hypoxic conditions [30, 43] . Freshly isolated ESPs, especially from the stromal-enriched fraction, also favored hypoxia for clonogenic growth [24] . Hypoxia is known to promote the growth of a variety of adult stem cells [44] [45] [46] , implying that fESP proliferation needs a hypoxic niche, or, alternatively, that fESPs are sensitive to a high oxygen environment. In addition, SP cell lines were established from fESPs when cultured under hypoxic conditions [47] .
IN VITRO DIFFERENTIATION POTENTIAL OF fESPS
Freshly isolated ESPs give rise to three distinct types of colonies in culture [23] . The most frequent type is comprised of fibroblastic stromal cells positive for CD13, an endometrial stromal cell marker. The second most frequent type displayed a MASUDA ET AL. cobblestone appearance of CD31 (endothelial marker) -positive cells. The least frequent type of colony formed small nests comprised of epithelial cells positive for cytokeratin, an endometrial epithelial marker. In contrast, most of the colonies in the fEMP cultures were comprised of CD13-positive fibroblastic stromal cells. Freshly isolated ESPs, but not fEMPs, possessed tissue stem/progenitor cell multipotency, generating three lineages of cell types in endometrium, including stromal, endothelial and epithelial cells. However, we could not show in vitro multipotency of single SP cells due to their lack of clonogenic activity. In our experience, colonies derived from fESPs appeared to be heterogeneous, which means that fESPs might contain several types of stem/ progenitor cells [23] . Unfortunately, at this stage, there is no evidence that fESPs are real stem cells that can commit to several types of progenitor cells in that culture at the single-cell level. It was also discovered that fESPs and fESP-derived cell lines could differentiate into several mesodermal lineages in vitro, including adipocytes and osteocytes, following their expansion under hypoxic conditions [24, 47] . Specifically, such multipotency of fESPs needs to be verified in single-cellderived clones in the future.
IN VIVO TISSUE RECONSTITUTING ABILITY OF fESPS
Our xenotransplantation study revealed, for the first time, the in vivo tissue-regenerative ability of fESPs [23] . Freshly isolated ESPs reconstituted a greater variety of endometrial tissue components than fEMPs when transplanted under the kidney capsule of NOD/SCID/c(c)null (NOG) mice [48] . We designated these reconstructs as ''glandular type,'' ''vascular endothelial type,'' ''migrating endothelial type,'' and ''stromal type,'' based on the dominant type of human structures or cell components present in the reconstructed tissue. Notably, fESPs, but not fEMPs, reconstituted the entire spectrum of endometrial-like tissues containing glandular structures, stromal tissue, and blood vessels. These results suggest that fESPs contained a single or several stem/progenitor populations able to regenerate the entire endometrium. However, only 8% of the mice xenotransplanted with fESPs reconstituted well-organized endometrium-like tissue, which we designated as ''glandular type'' [23] . This may indicate the relative frequency of the different stem/progenitor types in the fESPs. Alternatively, this low efficiency of in vivo reconstitution and in vitro clonogenic culture may be due to a lack of ''niche.'' Subcutaneous injection of cultured fESPs, which are not cESPs, into NOD/ SCID mice also showed lower success rates [24] . Freshly isolated ESPs may require a specific niche to reconstitute the entire endometrium in vivo as well as in in vitro culture. Indeed, the 100% reconstitution rate of singly dissociated endometrial cells containing both fESPs and fEMPs [49] and successful coculture of fESPs and fEMPs [23] substantiate our speculation that fEMPs may provide supporting niche cells appropriate for activation of the fESPs. To verify this ENDOMETRIAL SIDE POPULATION CELLS speculation, we recently developed an in vivo endometrial assay system. The fESPs or fEMPs lentivirally labeled with tdTomato were transplanted under the kidney capsule of NOG mice with unlabelled unfractionated endometrial cells [50] . As a result, more labeled cells were identified in the glandular, stromal, and endothelial components of all the reconstituted endometria in mice transplanted with fESPs compared to those with fEMPs [50] . This indicates that some of the unfractionated endometrial cells can provide a niche for fESPs, and fESPs can differentiate into multiple endometrial lineages more efficiently than fEMPs. Interestingly, fESP-derived cell lines from both stromal and epithelial fractions reconstituted endometrial-like tissues in all cases [47] . Importantly, these cell lines were established from fESPs cultured under hypoxic condition prior to implantation and cannot be considered cESPs. [22] [23] [24] . However, a crucial difference has not yet been fully identified. We showed that fESP cells, but not fEMP cells, express estrogen receptor (ER) b. In contrast, fEMPs, but not fESPs, express ERa and progesterone receptor (PR). Similarly, fESP-derived cell lines do not express ERa and PR [47] , although the expression of ERb was not examined. In murine endometrium, epithelial LRCs do not express ERa, and only 16% of stromal LRCs express ERa, but their proliferation was induced by estrogen administration, likely through an indirect effect mediated by niche cells [32] . A similar expression pattern was observed in human endometrial vascular endothelial cells, which express ERb, but not ERa or PR [51] . Similarly, human myometrial endothelial cells always express ERb, but ERa expression was variable [52] , and human bone marrow-derived endothelial progenitor cells (EPCs) express ERb [53] . In this context, the direct effect of estrogen is likely to be mediated by ERb [54] . It has been discovered that the lack of ERb led to hyperproliferation of murine endometrium [55] . These findings support endothelial cell-like properties and location of fESPs, and may imply that fESPs regulate progenitor/transit-amplifying cells via ERb (for further discussions about ERb, please refer to the section, ESP Cells and Endometrial Neoplastic Disease).
DIFFERENTIAL EXPRESSION OF ESTROGEN RECEPTOR
a AND ESTROGEN RECEPTOR b IN fESPS AND fEMPS Our in vivo and in vitro data have demonstrated functional differences between ESP and EMP cells. Some reports show differential expression of surface markers on these two populations
LOCATION OF SP CELLS IN HUMAN ENDOMETRIUM
Endometrial stem/progenitor cells were believed to reside in the basalis layer of the human endometrium [56] . We therefore anticipated that SP cells would be predominantly located in the basalis layer. However, immunostaining for ABCG2, a characteristic marker of SP cells, which presumably contains the fESPs, was, in fact, evenly distributed across both the functionalis and basalis layers of endometrium [23] . Most ABCG2-positive cells coexpressed CD31 and were preferentially located in small capillaries rather than large vessels [23] . Interestingly, endometrial mesenchymal stem-like cells (eMSCs) expressing PDGFRb and CD146 or W5C5 are perivascular in location [42, 57] . Thus, ABCG2-positive cells reside in a similar location to eMSCs, suggesting that ESPs and eMSCs may be closely related as constituents of an as-yetunidentified endometrial stem cell hierarchy. Furthermore, as EPCs are thought to originate from bone marrow [58] , the endothelial location of ABCG2-positive cells encouraged us to speculate that fESPs may originally be derived from bone marrow [23] . Indeed, bone marrow-derived EPCs contribute to the regeneration of blood vessels in both human and murine endometrium [53, 59] . Additionally, bone marrow-derived cells migrate into uterine endometrium of both humans [60] and mice [61, 62] . These reports support the possibility that fESPs may have originated from bone marrow, which may explain the distribution of ABCG2-positive cells throughout the endometrium. In contrast, fESPs of endometria from women who received bone marrow transplantation from male donors did not include XY donor-derived cells [63] . However, this report demonstrated that the proportion of fESPs in these women was very low compared to nontransplanted women, possibly because of chemotherapies that they received [63] , and their endometria might not have functioned appropriately under abnormal physiological conditions. Further study on the origin of fESPs is expected in the near future.
ESP CELLS AND ENDOMETRIAL NEOPLASTIC DISEASE
Accumulating evidence indicates that cancers contain a small subset of their own stem-like cells, termed cancer stem cells (CSCs) [64] [65] [66] [67] , which play critical roles in the initiation, maintenance, and recurrence of tumors. Rare clonogenic, selfrenewing, differentiating, and tumorgenic endometrial cancer epithelial cells were demonstrated in human endometrial cancer samples, indicating that endometrial cancer contains a CSC population that may be responsible for its initiation, progression, and metastasis [68] . It is possible that human endometrial stem/progenitor cells are targets of carcinogenesis, and an understanding of the endometrial stem/progenitor cells may open the way to new treatments of endometrial cancer [68] . SP cells are enriched in the CSC population in several types of cancer [69] [70] [71] , and are also considered responsible for drug resistance based on their ability to efflux chemotherapeutic drugs through the transporter, ABCG2. SP cells have also been identified in human endometrial cancer samples [72] and endometrial cancer cell lines [72] [73] [74] [75] [76] . These SP cells demonstrated CSC properties, including poor expression of differentiation markers, long-term proliferative capacity, selfrenewal capacity, enhanced migration, tumorgenicity, and high resistance to conventional chemotherapeutic drugs [72, 73, 75] . Additionally, epithelial-to-mesenchymal transition of these SP cells was demonstrated [72] , indicating that stromal cells in cancer tumors may be derived from CSCs, and that these SP cells may be involved in the development of endometrial stromal sarcoma or carcinosarcoma of the uterus [77] . Cells of well-differentiated endometrial cancer generally express the classic steroid receptors, ERa and PR-A [78, 79] . Recently, an association between ERb and ovarian invasion in uterine endometrioid adenocarcinomas has been demonstrated [80] . In contrast, fESPs express ERb, but not ERa or PR-A, and have unique migratory in vivo activity, shown as ''migrating endothelial type'' [23] . These similarities suggest a possible involvement of fESPs in the pathogenesis of endometrioid adenocarcinomas. However, it still remains unclear whether cancer SP cells arise from normal SP cells in any tissue. CD133 (reliable marker for endometrial CSCs) [81] [82] [83] -positive cells did not greatly overlap with endometrial cancer SP cells in a preliminary experiment [84] . Similarly, CD133-positive endometrial epithelial cells did not correspond with SP cells from fresh normal endometria (our unpublished data).
Similar to the concept of tumor-initiating cells having CSC properties, it has been postulated that endometrial stem/ progenitor cells are the most likely candidate for human endometriosis-initiating cells that generate ectopic endometriotic lesion [56] . Based on the implantation theory of endometriosis [85] , endometriosis-initiating cells in retrograde MASUDA ET AL. menstruation are likely to be derived from the functionalis layer, which contains abundant ABCG2-positive cells. Given the endothelial cell-like properties and the invasive feature of fESPs [23] , it is tempting to speculate that fESPs present in the functional layer may play a role in angiogenesis, essential for the establishment and survival of endometriotic lesions. Furthermore, the expression levels of ERb in ectopic endometrium are strikingly higher than those of ERa and PR in endometriotic lesions [86] , raising the possibility that ERbpositive fESPs may be involved in the pathogenesis of endometriosis. Together with the potential of fESPs for multidifferentiation into various types of endometrial cells [23] , our results collectively suggest that fESPs have the potential to generate endometriotic lesions through their unique migratory, angiogenic, and multidifferentiation [87] [88] [89] activities, which endorse local application of antiangiogenic therapy as a potential treatment for endometriosis [90, 91] . Moreover, endometriosis is associated with both ovarian clear-cell and endometrioid carcinomas [92] [93] [94] . Genetic investigation into the transformation of endometriosis in both carcinomas is just emerging, and warrants further study [95] . It is possible that fESPs are transformed into CSCs of certain types of ovarian cancer via endometriosis-initiating cells.
LIMITATIONS OF THE SP TECHNIQUE
Although accumulating evidence shows that SP cells are enriched for stem cells in a variety of organs, the most important and controversial issue is heterogeneity of SP cells. Actually, clinical application may not necessarily need a pure population of stem cells. However, for stem cell biology and understanding endometrial physiology, it is necessary to obtain single SP cells to show multipotency. Second, the SP is a small fraction of cells displaying low Hoechst fluorescence on flow cytometry plots, determined by disappearance of the fraction when the cells are treated with an ABCG2 inhibitor. Cell preparation, determining the flow cytometry settings, and analysis are difficult and cumbersome procedures. Uptake and efflux of the Hoechst dye is dynamic and influenced by the length and temperature of incubation [96] . This technical challenge also limits the ability to colabel unsorted SP cells with other markers. Additionally, the cytotoxicity of Hoechst dye and cellular damage caused by flow cytometry sorting should also be considered. Indeed, we demonstrated that flow cytometry sorting was detrimental to cell viability compared to magnetic bead selection [42] . Therefore, we must develop new methods to purify stem cells in the future on the basis of the data obtained from the further investigation of SP cells, including single-cell experiments.
TECHNICAL LIMITATIONS OF STUDIES IN HUMAN ENDOMETRIUM
There are several difficulties in undertaking investigations in human endometrium. First, humans have a unique pattern of menstrual cycles resulting in rapid changes in the growth and differentiation of endometrium in response to female sex hormones. So dynamic is human endometrium that it differs from day to day and even within the same tissue, making it necessary to categorize tissue samples according to menstrual cycle date. Additionally, human endometrium becomes highly differentiated in preparation for pregnancy. When sex steroid hormones fall in the absence of pregnancy, menstruation ensues, an event that is limited to humans and Old World primates, elephant shrews, and some bats [97] [98] [99] . Therefore, it is difficult to mimic human endometrium using small experimental animals, which have a 4-day estrus cycle lacking a progesterone-dominant phase and menstrual shedding. These features make it difficult to investigate human endometrium. However, we have utilized a mouse model of menstrual breakdown and repair for detection of LRC rather than for SP characterization, because this mouse ''menstrual'' model is more suitable for histological analysis than tissue dissociation and SP sorting, due to the variation in response along the length of the rodent uterus [34] . Furthermore, methods for dissociating endometrial tissue from rodents include the myometrium, which also has its own SP [30] , making it difficult to distinguish between the tissue types.
Second, the interface between endometrium and myometrium is quite irregular. This interface is deeply indented, and the basalis layer often penetrates into the myometrium, making it difficult to examine the deep basalis even after strong scraping with the back edge of a scalpel. It is possible that the deeppenetrating pockets of endometrium at the interface may harbor endometrial stem/progenitor cells that cannot be collected by scraping.
In addition, endometrium is composed of many types of cells, including stromal, epithelial, endothelial, immune, and blood cells, which change in different ways during the menstrual cycle. Human endometrial cells are usually separated into two fractions based on the differential rates of breakdown during enzymatic digestion. Mild enzymatic digestion using collagenase I or III gives rise to a single cell suspension which can pass through a filter and mainly comprises several types of stromal cells and leukocytes. Therefore, most researchers use this collagenase I or III-digestible cell population as the ''stromal (-enriched) fraction,'' which appears in the filtrate. In contrast, the collagenase I or III-undigestible fragments that are trapped on a filter mainly contain epithelial cells, and are therefore used as ''epithelial (-enriched) fraction,'' are further dissociated using trypsin or collagenase II digestion. However, these fractionation methods are crude and the stromal fraction will be contaminated with varying proportions of epithelial cells, and vice versa. Indeed, flow cytometric data of both stromal and epithelial SP fractions revealed that the expression of several lineage markers (CD9, CD13, CD31, and CD45) in both of these fractions partially overlapped (data not shown). For these reasons, we have investigated fESPs derived from unselected whole endometrial cells, although we found fESPs in both stromal-and epithelial-enriched fractions [23] . Gravitybased sedimentation after enzymatic digestion and filtration also reveals mutual contamination by flow cytometric analysis [24] . Magnetic bead selection using EpCAM Dynabeads (epithelial marker) substantially increases the purity of the epithelial and stromal fractions [39] , but not to 100%. In terms of purity, flow cytometric sorting is the most reliable, but the sorting is detrimental to the cells in terms of cell damage, as demonstrated by the reduction in clonogenic capacity of W5C5-positive and PDGFRb þ CD146 þ cells [42, 57] . Further improvements in obtaining highly purified epithelial and stromal cell fractions from freshly isolated human endometrial cell suspensions will assist in future studies examining these cells from human endometrium, although it is unknown if real endometrial stem cells express lineage markers such as CD9 or CD10. Moreover, it has been recently reported that mesenchymal-epithelial transition occurs in murine endometrial regeneration [100, 101] .
These unsolved issues complicate stem cell biology in endometrium and contribute to the unresolved issue of whether there exists a single endometrial stem/progenitor cell that generates both stromal and epithelial cells, and exactly where such a stem cell might be located.
ENDOMETRIAL SIDE POPULATION CELLS

CONCLUDING REMARKS
ESP cells generate endometrial endothelial, epithelial, and stromal cells in vitro and in vivo, and are located not only in the basalis, but also in the functionalis. An increasing body of evidence indicates that endometrial stem/progenitor cells are enriched in the ESP cell fraction, although the identity of SP cells in any tissue still remains unclear. This SP is still heterogeneous, indicating that the next step will be to examine ESP cells at the single-cell level and to purify the real stem/ progenitor cell population from ESP cells. However, from a clinical application perspective, enrichment of endometrial stem/progenitor cells may be sufficient, as the contaminating cells may provide essential niche factors. Additionally, we need to address the difference between cESPs and fESPs. To determine the position of ESP cells in the endometrial stem cell hierarchy, further studies are required to clarify their relationship to the other stem cell candidates [56] , such as PDGFRb þ CD146 þ [57] or W5C5 þ eMSCs [42] and clonogenic cells [41] . The study of ESP cells may also provide a breakthrough in our understanding of not only the physiology of endometrium, but also the pathophysiology of endometrial neoplastic disorders, such as endometriosis and endometrial cancer.
